MENU

Amarin (AMRN) Ownership - Who owns Amarin?

Profile

Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
357.53M
P/E Ratio
67.11
Total Cash
320.66M
Projected Growth
N/A
Total Debt
8.74M
Revenue
306.91M
Risk (Beta)
0.81
Dividend Yield
N/A
Total Cash/Share
0.80
Total Debt/Equity
N/A
Revenue/Share
0.75 USD as % of share price

Fundamentals

AMRN
Capitalization
358M
P/E Ratio
67.11
Risk (Beta)
0.81
Dividend Yield
N/A
Total Cash
321M
Total Cash/Share
0.80
Total Debt
8.74M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.75%
Revenue
307M
ROE
N/A
Book Value
552M
P/B Ratio
0.64
Cash Flow
N/A
Earnings
-0.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
303M
Current Ratio
2.80
Current Revenue Per Employee
271683.62
Dividends Per Share - Security
N/A
EBITDA
-50.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.40
Revenue To Assets
-6.88
Shares Held By Institutions
83.2M
Shares Outstanding - Current
401M
Total Liabilities
280M
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.736
View a ticker or compare two or three
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com